IDH1 and central nervous system neoplasm: According to the 2021 WHO Classification of CNS Tumors, Fifth Edition, if the IDH mutation is positive, it is termed astrocytoma, and if the IDH mutation is negative (IDH-wildtype), it is termed glioblastoma.